Control Material for Quality Control of Qualitative Detection of Antibodies to Hepatitis B Virus Core Antigen (Anti-HBc) in Clinical Samples by Chemiluminescent Immunoassay on CL Series Analyzers

We present a control material designed for quality control of qualitative detection of antibodies to the Hepatitis B virus core antigen (Anti-HBc) using the chemiluminescent immunoassay method on CL series analyzers. The following options are available:

Option 1

Negative control material (Anti-HBc Negative Control) in clinical samples, 3 vials of 2.0 ml each. Includes:

Anti-HBc Negative Control, 2.0 ml – 3 vials
Control material series value table
User manual

Option 2

Negative control material (Anti-HBc Negative Control) in clinical samples, 6 vials of 2.0 ml each. Includes:

Anti-HBc Negative Control, 2.0 ml – 6 vials
Control material series value table
User manual

Option 3

Positive control material (Anti-HBc Positive Control) in clinical samples, 3 vials of 2.0 ml each. Includes:

Anti-HBc Positive Control, 2.0 ml – 3 vials
Control material series value table
User manual

Option 4

Positive control material (Anti-HBc Positive Control) in clinical samples, 6 vials of 2.0 ml each. Includes:

Anti-HBc Positive Control, 2.0 ml – 6 vials
Control material series value table
User manual

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Control Material for Quality Control of Qualitative Detection of Antibodies to Hepatitis B Virus Core Antigen (Anti-HBc) in Clinical Samples by Chemiluminescent Immunoassay on CL Series Analyzers, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Back